Nanotechnology lights up the antitumor potency by combining chemotherapy with siRNA
- 22 July 2021
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 9 (36) , 7302-7317
Abstract
This review summarizes the latest nanosystems with different functional nanomaterials that co-load and protect the siRNA/drugs, precisely target tumors, and release cargoes intelligently.Keywords
Funding Information
- National Natural Science Foundation of China (81703940)
- Priority Academic Program Development of Jiangsu Higher Education Institutions (2019YSHL019)
- Qinglan Project of Jiangsu Province of China (2021)
This publication has 124 references indexed in Scilit:
- Near-infrared absorbing mesoporous carbon nanoparticle as an intelligent drug carrier for dual-triggered synergistic cancer therapyCarbon, 2015
- Stimuli-sensitive nanopreparations for combination cancer therapyJournal of Controlled Release, 2014
- Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core–shell nanoparticlesBiomaterials, 2014
- A Multi‐synergistic Platform for Sequential Irradiation‐Activated High‐Performance Apoptotic Cancer TherapyAdvanced Functional Materials, 2013
- Bioresponsive Hyaluronic Acid‐Capped Mesoporous Silica Nanoparticles for Targeted Drug DeliveryChemistry – A European Journal, 2013
- Biomineralization inspired surface engineering of nanocarriers for pH-responsive, targeted drug deliveryBiomaterials, 2013
- RNA Interference: Big Applause for Silencing in StockholmCell, 2006
- RNA interference: unraveling a mysteryNature Structural & Molecular Biology, 2006
- The Human Genome Project: Lessons from Large-Scale BiologyScience, 2003
- A brief history of gene therapyNature Genetics, 1992